Vantage Biosciences
PrivateLast Round
Seed
Jul 19, 2023
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vantage Biosciences operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in July 2023.
Vantage Biosciences is a biotechnology company that develops novel oral therapies for inflammatory conditions, including diabetic retinopathy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vantage Biosciences Comparables
Compare Vantage Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Breye Therapeutics | 87% | |
| Opus Genetics | 79% | |
| Boehringer Ingelheim | 72% |
For institutional investors. Book with your work email.
Vantage Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Vantage Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ALSA Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 44% MoM.
- Jun 17, 2026
Monthly visitors grew 151% MoM, from 456 to 1.1K.
For institutional investors. Book with your work email.
Vantage Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vantage Biosciences's valuation, stock price, and market status.
Is Vantage Biosciences a public or private company?
Vantage Biosciences is a private company.
What is the current stock price of Vantage Biosciences?
Vantage Biosciences is a private company, so its shares have no public market price. Caplight tracks Vantage Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vantage Biosciences worth (valuation)?
Valuation information for Vantage Biosciences is not publicly available.
Can I buy Vantage Biosciences stock?
Vantage Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vantage Biosciences's last funding round?
Vantage Biosciences's most recent funding round was Seed on July 19, 2023.
Who are the main investors in Vantage Biosciences?
Key investors in Vantage Biosciences include ALSA Ventures.
Will Vantage Biosciences IPO soon?
No public IPO plans have been announced for Vantage Biosciences.
How can I track Vantage Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Vantage Biosciences's shares on secondary markets.